The adaptive immune system is renowned for its vast diversity of antibody and T-cell receptor specificities. The mechanisms generating this diversity—V(D)J recombination and somatic hypermutation—are unique and highly regarded by scientists in various biological fields. However, another crucial aspect of diversity often overlooked by those outside immunology is the extensive range of immune effector mechanisms, both antibody- and cell-mediated, that provide protection. For humoral responses, this diversity in the biological properties of antibodies—including structural variations, mechanisms for pathogen elimination, ability to traverse tissue layers into different body fluids, resistance to degradation, and longevity in circulation—stems from sequence variation in the constant regions of heavy chain classes and subclasses. These differences evolved in vertebrates due to the adaptive advantage of producing antibodies capable of neutralizing pathogens and targeting infected or tumor cells through multiple mechanisms. These mechanisms include neutralizing and agglutinating antigens, enhancing phagocytosis via opsonization, activating complement pathways leading to cell lysis, inducing antibody-dependent cell-mediated cytotoxicity, and triggering degranulation and mediator release. To enable the generation of antibodies with such diverse functions, the immune system developed a third unique gene-altering process known as heavy-chain class switch recombination (CSR). CSR allows naïve B cells with IgM and IgD B-cell receptors to produce antibody-secreting plasma cells capable of generating antibodies of other classes better suited to combat an invading pathogen. As previously discussed, the regulation of the heavy chain ultimately expressed in an activated B cell reflects this remarkable adaptability.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Transcript

Related